Item Type | Name |
Academic Article
|
Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy.
|
Academic Article
|
Male breast cancer during treatment with leuprolide for prostate cancer.
|
Academic Article
|
Masculinity and the body: how African American and White men experience cancer screening exams involving the rectum.
|
Academic Article
|
Men's knowledge and beliefs about prostate cancer: education, race, and screening status.
|
Academic Article
|
The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function.
|
Academic Article
|
Dosimetric quantifiers for low-dose-rate prostate brachytherapy: is V(100) superior to D(90)?
|
Academic Article
|
A simple model predicts freedom from biochemical recurrence after low-dose rate prostate brachytherapy alone.
|
Academic Article
|
Pretreatment prostate-specific antigen velocity is associated with freedom from biochemical recurrence of prostate cancer after low-dose-rate prostate brachytherapy alone.
|
Concept
|
Prostatic Neoplasms
|
Academic Article
|
DNA damage levels in prostate cancer cases and controls.
|
Academic Article
|
A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry.
|
Academic Article
|
Racial and Socioeconomic Disparities in MRI-Fusion Biopsy Utilization to Assess for Prostate Cancer.
|
Academic Article
|
Racial Disparities in Prostate Specific Antigen Screening and Referral to Urology in a Large, Integrated Health Care System: A Retrospective Cohort Study.
|
Academic Article
|
Identification of Genes Required for Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cells In Vitro.
|
Academic Article
|
Increased nuclear factor I/B expression in prostate cancer correlates with AR expression.
|
Academic Article
|
A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry.
|
Academic Article
|
MAGI2 is an independent predictor of biochemical recurrence in prostate cancer.
|
Academic Article
|
Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry.
|
Academic Article
|
MAGI-2 Is a Sensitive and Specific Marker of Prostatic Adenocarcinoma: ?A Comparison With AMACR.
|
Academic Article
|
NF-?B and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance.
|
Academic Article
|
MAGI-2 in prostate cancer: an immunohistochemical study.
|
Academic Article
|
Nfib Regulates Transcriptional Networks That Control the Development of Prostatic Hyperplasia.
|
Academic Article
|
Biochemical recurrence-free survival after robotic-assisted laparoscopic vs open radical prostatectomy for intermediate- and high-risk prostate cancer.
|
Academic Article
|
NF-?B gene signature predicts prostate cancer progression.
|
Academic Article
|
Salvage robotic assisted laparoscopic radical prostatectomy: a single institution, 5-year experience.
|
Academic Article
|
Prostate size as a predictor of Gleason score upgrading in patients with low risk prostate cancer.
|
Academic Article
|
Tumor volume as a predictor of adverse pathologic features and biochemical recurrence (BCR) in radical prostatectomy specimens: a tale of two methods.
|
Academic Article
|
Serum methionine metabolites are risk factors for metastatic prostate cancer progression.
|
Academic Article
|
Comparative analysis of whole mount processing and systematic sampling of radical prostatectomy specimens: pathological outcomes and risk of biochemical recurrence.
|
Academic Article
|
Comparison of transfusion requirements between open and robotic-assisted laparoscopic radical prostatectomy.
|
Academic Article
|
Smaller prostate size predicts high grade prostate cancer at final pathology.
|
Academic Article
|
Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology.
|
Academic Article
|
Robotic assisted laparoscopic prostatectomy versus radical retropubic prostatectomy for clinically localized prostate cancer: comparison of short-term biochemical recurrence-free survival.
|
Academic Article
|
Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology.
|
Academic Article
|
Impact of positive apical surgical margins on likelihood of biochemical recurrence after radical prostatectomy.
|
Academic Article
|
Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomy.
|
Academic Article
|
Outcomes of patients undergoing radical cystoprostatectomy for bladder cancer with prostatic involvement on final pathology.
|
Academic Article
|
Risk factors for urothelial carcinoma of the prostate in patients undergoing radical cystoprostatectomy for bladder cancer.
|
Academic Article
|
Cytokine genetic polymorphisms and prostate cancer aggressiveness.
|
Academic Article
|
Intake of plant foods and associated nutrients in prostate cancer risk.
|
Academic Article
|
Bladder cancer.
|
Academic Article
|
Chemokine markers predict biochemical recurrence of prostate cancer following prostatectomy.
|
Academic Article
|
Effect of a large prostate gland on open and robotically assisted laparoscopic radical prostatectomy.
|
Academic Article
|
Interactions of cytokine gene polymorphisms in prostate cancer risk.
|
Academic Article
|
A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy.
|
Academic Article
|
Does a delay in initiating definitive therapy affect biochemical recurrence rates in men with clinically localized prostate cancer?
|
Academic Article
|
Vinorelbine, doxorubicin, and prednisone in androgen-independent prostate cancer.
|
Academic Article
|
Complementary and alternative medicine for advanced prostate cancer.
|
Academic Article
|
Percentage of positive biopsies associated with freedom from biochemical recurrence after low-dose-rate prostate brachytherapy alone for clinically localized prostate cancer.
|
Academic Article
|
Prostate cancer and bone metastases: medical treatment.
|
Academic Article
|
The androgen receptor CAG repeat and prostate cancer risk.
|
Academic Article
|
Androgen receptor activity at the prostate specific antigen locus: steroidal and non-steroidal mechanisms.
|
Academic Article
|
Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer.
|